Skip to content

We strive to contribute to progress through the development of innovative technologies and sustainable solutions, according to the latest GMP (Good Manufacturing Practice) regulations. We continue to implement large investments in Research & Development in order to be at the forefront and maintain a technological advantage in the sector. In the field of Pharma for aseptic processing of pharmaceutical products Comecer develops standard and tailored solutions for the production of isolators for the treatment of toxic and non-toxic substances to be used in pharmaceutical production companies, in university research centres, in hospitals, and in small as well as in large industrial groups worldwide. We gained experience in manual and semi-automatic sterile processing of cytotoxic antiblastic drugs in hospital pharmacies. All systems are tested and undergo a comprehensive series of validation checks according to the applicable standards and norms. The “Safety First” Code of Ethics applies inside Comecer, which translates into quality of materials and processes and allows Comecer to qualify its products in accordance with the highest standards in the sector.

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.